Cargando…

Efficacy and safety of calcium carbonate in normophosphataemic patients with chronic kidney disease Stages 3 and 4

BACKGROUND: Disordered bone and mineral metabolism are a common complication of chronic kidney disease (CKD). Phosphate binders are often prescribed in advanced CKD, when hyperphosphataemia develops. Little is known about the role of these drugs in earlier stages, when serum phosphorus levels are ke...

Descripción completa

Detalles Bibliográficos
Autores principales:	Neto, Ricardo, Frazão, João
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886574/ https://www.ncbi.nlm.nih.gov/pubmed/33623678 http://dx.doi.org/10.1093/ckj/sfz181

Ejemplares similares

Short-term effects of sevelamer-carbonate on fibroblast growth factor 23 and pulse wave velocity in patients with normophosphataemic chronic kidney disease Stage 3
por: Bouma-de Krijger, Annet, et al.
Publicado: (2019)

Sclerostin and DKK1 circulating levels associate with low bone turnover in patients with chronic kidney disease Stages 3 and 4
por: Neto, Ricardo, et al.
Publicado: (2021)

Oral calcium carbonate affects calcium but not phosphorus balance in stage 3–4 chronic kidney disease
por: Hill, Kathleen M., et al.
Publicado: (2012)

Efficacy and safety of paricalcitol in children with stages 3 to 5 chronic kidney disease
por: Webb, Nicholas J. A., et al.
Publicado: (2017)

Efficacy and safety of oral doxercalciferol in the management of secondary hyperparathyroidism in chronic kidney disease stage 4
por: Dheerendra, P. C., et al.
Publicado: (2013)

Low serum calcium is associated with poor renal outcomes in chronic kidney disease stages 3–4 patients
por: Lim, Lee-Moay, et al.
Publicado: (2014)

Efficacy and safety of calcium polystyrene sulfonate in patients with hyperkalemia and stage 3–5 non-dialysis chronic kidney disease: a single-center randomized controlled trial
por: Wang, Xia, et al.
Publicado: (2023)

Safety and Efficacy of Apixaban vs Warfarin in Patients With Stage 4 and 5 Chronic Kidney Disease: A Systematic Review
por: Fatima, Hameeda, et al.
Publicado: (2022)

Efficacy and Safety of Sucroferric Oxyhydroxide and Calcium Carbonate in Hemodialysis Patients
por: Koiwa, Fumihiko, et al.
Publicado: (2017)

Safety and Efficacy of Exenatide Once Weekly in Participants with Type 2 Diabetes and Stage 2/3 Chronic Kidney Disease
por: Guja, Cristian, et al.
Publicado: (2020)

Renal safety and urate-lowering efficacy of febuxostat in gout patients with stage 4–5 chronic kidney disease not yet on dialysis
por: Kim, Sang-Hyon, et al.
Publicado: (2020)

Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease
por: Yale, J-F, et al.
Publicado: (2013)

Correction to: Safety and Efficacy of Exenatide Once Weekly in Participants with Type 2 Diabetes and Stage 2/3 Chronic Kidney Disease
por: Guja, Cristian, et al.
Publicado: (2020)

Magnesium in chronic kidney disease Stages 3 and 4 and in dialysis patients
por: Cunningham, John, et al.
Publicado: (2012)

Effect of lanthanum carbonate and calcium acetate in the treatment of hyperphosphatemia in patients of chronic kidney disease
por: Scaria, P. Thomas, et al.
Publicado: (2009)

Efficacy of Statin Treatment in Early-Stage Chronic Kidney Disease
por: Cho, Eun Yeong, et al.
Publicado: (2017)

Cardiovascular risk markers associated with arterial calcification in patients with chronic kidney disease Stages 3 and 4
por: Kiu Weber, Chek Ing, et al.
Publicado: (2014)

Case report: Safety and efficacy of voxelotor in a patient with sickle cell disease and stage IV chronic kidney disease
por: Alshurafa, Awni, et al.
Publicado: (2022)

Calcium Balance in Chronic Kidney Disease
por: Hill Gallant, Kathleen M., et al.
Publicado: (2017)

Efficacy and safety of lanthanum carbonate on chronic kidney disease–mineral and bone disorder in dialysis patients: a systematic review
por: Zhang, Chenglong, et al.
Publicado: (2013)

Efficacy and safety of dapagliflozin in patients with type 2 diabetes and moderate renal impairment (chronic kidney disease stage 3A): The DERIVE Study
por: Fioretto, Paola, et al.
Publicado: (2018)

Efficacy and safety of a low-sodium diet and spironolactone in patients with stage 1-3a chronic kidney disease: a pilot study
por: Zhang, Hongmei, et al.
Publicado: (2022)

A randomized, double-blind, placebo-controlled study of the safety and tolerance of regadenoson in subjects with stage 3 or 4 chronic kidney disease
por: Ananthasubramaniam, Karthik, et al.
Publicado: (2012)

Prevalence and determinants of sarcopenia in Indian patients with chronic kidney disease stage 3 & 4
por: Dubey, Avinash Kumar, et al.
Publicado: (2021)

Efficacy and Safety of Tanshinone for Chronic Kidney Disease: A Meta-Analysis
por: Zhou, Yao, et al.
Publicado: (2020)

Safety and efficacy of sucroferric oxyhydroxide in pediatric patients with chronic kidney disease
por: Greenbaum, Larry A., et al.
Publicado: (2020)

A Randomized Open-Label Clinical Study Comparing the Efficacy, Safety, and Bioavailability of Calcium Lysinate with Calcium Carbonate and Calcium Citrate Malate in Osteopenia Patients
por: Shankar, Kanthi, et al.
Publicado: (2018)

Oral Magnesium Supplementation in Chronic Kidney Disease Stages 3 and 4: Efficacy, Safety, and Effect on Serum Calcification Propensity—A Prospective Randomized Double-Blinded Placebo-Controlled Clinical Trial
por: Bressendorff, Iain, et al.
Publicado: (2016)

Efficacy of HBV Vaccination in Various Stages of Chronic Kidney Disease: Is Earlier Better?
por: Hashemi, Behnam, et al.
Publicado: (2011)

Paricalcitol does not improve glucose metabolism in patients with stage 3-4 chronic kidney disease
por: de Boer, Ian H., et al.
Publicado: (2012)

Could Bone Biomarkers Predict Bone Turnover after Kidney Transplantation?—A Proof-of-Concept Study
por: Magalhães, Juliana, et al.
Publicado: (2022)

Baseline characteristics of patients with chronic kidney disease stage 3 and stage 4 in spain: the MERENA observational cohort study
por: Martínez-Castelao, Alberto, et al.
Publicado: (2011)

The pregnancy outcomes in patients with stage 3–4 chronic kidney disease and the effects of pregnancy in the long-term kidney function
por: He, Yingdong, et al.
Publicado: (2018)

Urate-lowering agents for asymptomatic hyperuricemia in stage 3 – 4 chronic kidney disease: Controversial role of kidney function
por: Jeon, Hee Jung, et al.
Publicado: (2019)

The effects of calcitriol with calcium carbonate supplementation on inflammatory biomarkers in chronic kidney disease patients’ with low vitamin D
por: Mustafar, Ruslinda BT, et al.
Publicado: (2014)

Different Effect of Lanthanum Carbonate and Sevelamer Hydrochloride on Calcium Balance in Patients with Moderate to Advanced Chronic Kidney Disease
por: Makowka, Agnieszka, et al.
Publicado: (2021)

Effects of sevelamer carbonate versus calcium acetate on vascular calcification, inflammation, and endothelial dysfunction in chronic kidney disease
por: Mason, Darius L., et al.
Publicado: (2021)

Safety and efficacy of direct-acting antivirals for chronic hepatitis C in patients with chronic kidney disease
por: Iliescu, Elena Laura, et al.
Publicado: (2020)

Safety and efficacy of ferric citrate in patients with nondialysis-dependent chronic kidney disease
por: Chertow, Glenn M., et al.
Publicado: (2017)

A systematic review of the efficacy and safety of anticoagulants in advanced chronic kidney disease
por: Parker, Kathrine, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qdct8b13pe41agnhlc7i8uc2i4